Sylvin Ouedraogo

Sylvin Ouedraogo

Auto-generated profile, based on publicly available information

Sylvin Ouedraogo

Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Toxicology
Verified
Journal Article
Open access
JOJoël Ouédraogo
Joël Ouédraogo
SISylvain Ilboudo
Sylvain Ilboudo
GOGeoffroy Gueswindé Ouédraogo
Geoffroy Gueswindé Ouédraogo
VDVirginie Dakuyo
Virginie Dakuyo
SOSalfo Ouédraogo
Salfo Ouédraogo
SOSylvin Ouédraogo
Sylvin Ouédraogo
In response to the COVID‐19 pandemic and following the World Health Organization’s call for action, several traditional medicine recipes were used without any scientific prerequisites concerning their safety. The current study investigated several short‐term toxicity parameters of SAYE PLUS, an antimalarial phytomedicine used in COVID‐19 patients in Burkina Faso. Following the guidelines of the Organisation for Economic Co‐operation and Development (OECD), the safety profile of SAYE PLUS was investigated in a battery of tests in rats and mice. In an acute toxicity study, male and female rats received a single oral dose of 2000 mg/kg b.w. of the test substance. For the subacute toxicity test, male and female rats received daily oral doses of 250, 500, and 1000 mg/kg b.w. for 28 days. Acute and subacute toxicity tests were accompanied by food and water intake, body and organ relative weight, and blood chemistry of animals recording. In mutagenicity, sperm quality, and lipid peroxidation tests, mice were orally exposed to daily oral doses of 500, 1000, and 2000 mg/kg for seven days. Single dose of 2000 mg/kg b.w. of SAYE PLUS did not cause rats mortality. The LD 50 is more than 2000 mg/kg b.w. Daily administration of SAYE PLUS for 28 days did not induce any significant change in the water or food intake and the body or organ relative weights of animals. Furthermore, no significant change was observed in biochemical parameters. In the test conditions, the recipe did not induce an increase of micronucleus or changes in sperm motility and number. However, all tested doses of SAYE PLUS induced a significant increase in MDA levels in mice serum. These results show that SAYE PLUS did not induce negative impacts on studied parameters, but the possible lipidic peroxidation observed must be further investigated for its mechanism and effects.

10 September 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
WOWindingoudi Rimwagna Christian Ouedraogo
Windingoudi Rimwagna Christian Ouedraogo
MNMathieu Nitiema
Mathieu Nitiema
BKBoukaré Kabore
Boukaré Kabore
SCSouleymane COMPAORE
Souleymane COMPAORE
ATAristide Traore
Aristide Traore
SOSylvin Ouedraogo
Sylvin Ouedraogo
Vascular endothelium, in addition to functioning as a physical barrier, plays a crucial role in regulating blood pressure. Endothelial protective mechanisms offer an alternative way to prevent cardiovascular risks, including hypertension. This study aimed to demonstrate the vasculoprotective and antihypertensive potential of the ethyl acetate fraction of Phaseolus vulgaris (EPV) pods in mice. Naval Medical Research Institute (NMRI) mice were randomized, and hypertension was induced by oral administration of LNAME (Lῳ- Nitro Arginine Methyl Ester). Subsequently, EPV and captopril were administered to the hypertensive mice. Physical parameters, blood pressure components, and biochemical conditions were measured. Vascular protection was assessed by measuring NO-dependent vasorelaxation of the aortic ring in the study mice. Phytochemical analysis of EPV was performed by high-performance liquid chromatography-mass spectrometry. Captopril and EPV significantly reduced blood pressure in LNAME-induced hypertensive mice, with the most effective doses of 5 mg/kg captopril and 20 mg/kg EPV. Furthermore, two-way ANOVA with Bonferroni post-tests showed that mice treated with EPV responded better in aortic rings, with strong vasorelaxation in the presence of ACh (acetylcholine) and SNP (sodium nitroprusside), compared with mice treated with LNAME alone. The weight variation and biochemical parameters in high-tension mice improved significantly with doses of captopril and EPV. Molecules are known to have beneficial effects on cardiovascular health, most of which are chlorogenic acid, quercetin glucoside, and p-coumaroylquinic acid. This investigation showed that the EPV had antihypertensive and cardiovascular effects in LNAME hypertensive mice, as well as a protective effect on the vascular endothelium.

15 January 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
GOGeoffroy Gueswindé Ouedraogo
Geoffroy Gueswindé Ouedraogo
MBMohamed Bonewendé BELEMLILGA
Mohamed Bonewendé BELEMLILGA
TKTombègou Kouguilima
Tombègou Kouguilima
GSGaëtan Donzéo Somda
Gaëtan Donzéo Somda
SISylvain Ilboudo
Sylvain Ilboudo
SOSylvin Ouedraogo
Sylvin Ouedraogo
Balanites aegyptiaca (L.) Delile (Zygophyllaceae) is a medicinal plant used in traditional medicine in Burkina Faso to treat helminthiasis. Using an ethnopharmacological approach, the "Institut de Recherche en Sciences de la Santé (IRSS)" has developed a phytomedicine based on an almond extract from the fruit of this plant for the treatment of helminthiasis. This study aimed to assess the acute and subacute oral toxicity and in vivo mutagenicity of phytomedicine. The acute toxicity study was carried out following OECD guideline 423 by administering a single dose of 2000 mg/kg body weight (bw) of phytomedicine orally to female mice. For subacute toxicity, OECD guideline 407 was used. Four batches of 10 rats (5 males and 5 females) were used, including a control batch and three treated batches receiving a daily oral administration of the phytomedicine at doses of 250, 500, or 1000 mg/kg bw for 28 days. The mutagenicity test was performed according to OECD guideline 474; five batches of 10 mice (5 males and 5 females) were given oral doses of 500, 1000 or 2000 mg/kg bw of phytomedicine, colchicine as a positive control at 5mg/kg bw and distilled water as a negative control. In the acute toxicity test, the LD50 was estimated at 5000 mg/kg bw. The subacute toxicity study showed no mortality or signs of toxicity in rats. Biochemical analysis revealed no significant differences between control rats and those treated with the phytomedicine for glucose, creatinine, total cholesterol, triglycerides, AST, chlorine, calcium, and potassium. On the other hand, serum levels of ALT, total protein, PO43-, and Na+ were significantly reduced in some treated rats. The mutagenicity test showed no change in micronucleus frequency between treated and control mice. This study showed that phytomedicine based on an extract of B. aegyptiaca fines would present less danger to users. Keywords: Balanites aegyptiaca, acute toxicity, subacute toxicity, micronucleated erythrocytes, phytomedicine.

13 December 2024 in Journal of Public Health in Africa
Verified
Journal Article
Open access
PDF file
JDJeoffray Diendéré
Jeoffray Diendéré
TRToussaint Rouamba
Toussaint Rouamba
JKJean Kaboré
Jean Kaboré
AZAugustin N. Zeba
Augustin N. Zeba
HTHalidou Tinto
Halidou Tinto
SKSeni Kouanda
Seni Kouanda
Background: Excess body weight was associated with a higher chance for hypertension detection.Aim: To compare the anthropometric characteristics and blood pressure levels between Burkinabè adults who had ever been screened for hypertension and those who had never been screened, and to assess the associated factors with the uptake of hypertension screening.Setting: Urban and rural Burkina Faso.Methods: This was a secondary analysis using the Burkina Faso 2013 WHO Stepwise approach to Surveillance cross-sectional survey. Data from 3831 adult men and women were analysed. Descriptive and analytical analyses were performed using Student’s t, ANOVA, χ2, Fisher’s exact tests and logistic regression.Results: Among participants, 41.6% (95% CI: 40.0–43.1) had never been screened for hypertension, and compared to those who had ever been screened, they had significantly lower mean weight, waist circumference and body mass index, and lower prevalence of overweight or obesity and abdominal obesity. The prevalence of prehypertension was similar between the two groups (around 40%) and the prevalence of hypertension was lower in those who had never been screened (17.3% vs 20.8%; p = 0.007). Overweight or obesity (adjusted odds ratio [aOR] = 1.3; p = 0.03) and abdominal obesity (aOR = 1.3; p = 0.002) were associated with screening uptake.Conclusion: The Burkinabè adults who had never been screened for hypertension were apparently thin, but pre-hypertension or hypertension was also common among them. Increasing body size (excess weight or abdominal obesity) may be the reason for screening uptake.Contribution: Specific awareness-raising messages to motivate slim people to undergo screening need to be developed.

20 February 2025 in Pharmaceutical Science and Technology
Verified
Journal Article
Open access
PDF file
OSOuédraogo Salfo
Ouédraogo Salfo
ACAtchadé Boladé Constantin
Atchadé Boladé Constantin
TKTraoré Tata Kadiatou
Traoré Tata Kadiatou
RMRouamba Téyindé Songré Martin
Rouamba Téyindé Songré Martin
TSTraoré Safiatou
Traoré Safiatou
RSRASMANE SEMDE
RASMANE SEMDE
Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of Zanthoxylum zanthoxyloides and Calotropis procera. This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.

15 May 2026 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
WOWindingoudi Rimwagna Christian Ouedraogo
Windingoudi Rimwagna Christian Ouedraogo
MNMathieu Nitiema
Mathieu Nitiema
BKBoukaré Kabore
Boukaré Kabore
SCSouleymane COMPAORE
Souleymane COMPAORE
MKMoumouni Koala
Moumouni Koala
SOSylvin Ouedraogo
Sylvin Ouedraogo
Diuretics play an important role in managing high blood pressure. The aim of this study was to determine the organic acids, toxicity, and diuretic properties of the ethyl acetate fraction of Phaseolus vulgaris (EPV) in Wistar rats. High Performance Liquid Chromatography (HPLC) analysis has been used to detect and quantify the organic acids in the EPV fraction. Cytotoxicity tests of Artemia salina larvae and acute oral toxicity tests are carried out to determine the lethal concentrations and doses of EPV. The diuretic properties of EPV were evaluated in Wistar rats for 24 hours by measuring diuresis parameters and urinary electrolyte concentrations. Results: The HPLC analysis report showed the presence of various organic acids in EPV, including malic acid (117.79±0.01 mg/g), oxalic acid (52.47±0.00 mg/g), and citric acid (42.85±0.00 mg/g). EPV seems almost non-toxic, as demonstrated by the larvicidal death lethal concentration (LC50) and the estimated 50% lethal dose of 5000 mg/kg body weight. Measuring diuresis parameters reports that EPV may increase urine volume at the test doses. In addition, the report states that EPV affects electrolyte balance by increasing the excretion of Na+, K+, Cl+, and pH. The intensity of the diuretic effect was significantly higher than that of the negative control. These effects are less pronounced than those caused by pharmacological references but are largely similar to those caused by furosemide. A high concentration of oxalic acids, citric acids and ascorbic acids, combined with the proven urine effects of EPV, strengthens the antihypertension, antioxidant and vasorelaxant properties previously reported. These drug properties demonstrate not only the traditional use of EPV but also its use as a database for the development of innovative therapeutic tools to reduce the risk of cardiovascular diseases. Keywords: Diuretic effect; Organic acids; Phaseolus vulgaris ethyl acetate fraction